1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Healthcare-associated Infectious Disease Diagnostics Market, by Product & Service
6.1. Introduction
6.2. Assays, Kits, & Reagents
6.3. Instruments
6.4. Services & Software

7. Healthcare-associated Infectious Disease Diagnostics Market, by Disease Type
7.1. Introduction
7.2. Chlamydia Trachomatis Genital Infection and Gonorrhea
7.3. Hepatitis
7.4. Hospital-Acquired Infections
7.5. Human Immunodeficiency Virus
7.6. Human Papillomavirus
7.7. Influenza
7.8. Tuberculosis

8. Healthcare-associated Infectious Disease Diagnostics Market, by End-user
8.1. Introduction
8.2. Academic/Research Institutes
8.3. Hospital/Clinical Laboratories
8.4. Physician Offices
8.5. Reference Laboratories

9. California Healthcare-associated Infectious Disease Diagnostics Market

10. Florida Healthcare-associated Infectious Disease Diagnostics Market

11. Illinois Healthcare-associated Infectious Disease Diagnostics Market

12. New York Healthcare-associated Infectious Disease Diagnostics Market

13. Ohio Healthcare-associated Infectious Disease Diagnostics Market

14. Pennsylvania Healthcare-associated Infectious Disease Diagnostics Market

15. Texas Healthcare-associated Infectious Disease Diagnostics Market

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Abbott Laboratories
17.2. Becton, Dickinson and Company
17.3. Bio-Rad Laboratories, Inc.
17.4. Biomérieux SA
17.5. Co-Diagnostics Inc.
17.6. Danaher Corporation
17.7. DiaSorin S.p.A.
17.8. DNAe Group Holdings Ltd
17.9. GNA Biosolutions GmbH
17.10. Luminex Corporation
17.11. Meridian Bioscience Inc.
17.12. Quidel Corporation
17.13. Roche Holding AG
17.14. Siemens Healthineers AG
17.15. Thermo Fisher Scientific Inc.

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT & SERVICE, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT & SERVICE, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT & SERVICE, 2027
FIGURE 6. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SERVICES & SOFTWARE, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SERVICES & SOFTWARE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2020 VS 2027 (%)
FIGURE 13. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2020 VS 2027 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2027
FIGURE 15. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA TRACHOMATIS GENITAL INFECTION AND GONORRHEA, 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA TRACHOMATIS GENITAL INFECTION AND GONORRHEA, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HEPATITIS, 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HEPATITIS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL-ACQUIRED INFECTIONS, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL-ACQUIRED INFECTIONS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HUMAN IMMUNODEFICIENCY VIRUS, 2018-2027 (USD MILLION)
FIGURE 22. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HUMAN IMMUNODEFICIENCY VIRUS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 23. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HUMAN PAPILLOMAVIRUS, 2018-2027 (USD MILLION)
FIGURE 24. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HUMAN PAPILLOMAVIRUS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 25. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFLUENZA, 2018-2027 (USD MILLION)
FIGURE 26. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFLUENZA, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS, 2018-2027 (USD MILLION)
FIGURE 28. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 29. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2020 VS 2027 (%)
FIGURE 30. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2020 VS 2027 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2027
FIGURE 32. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ACADEMIC/RESEARCH INSTITUTES, 2018-2027 (USD MILLION)
FIGURE 33. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ACADEMIC/RESEARCH INSTITUTES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 34. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL/CLINICAL LABORATORIES, 2018-2027 (USD MILLION)
FIGURE 35. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL/CLINICAL LABORATORIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 36. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PHYSICIAN OFFICES, 2018-2027 (USD MILLION)
FIGURE 37. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PHYSICIAN OFFICES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 38. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REFERENCE LABORATORIES, 2018-2027 (USD MILLION)
FIGURE 39. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REFERENCE LABORATORIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 40. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 41. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 42. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SERVICES & SOFTWARE, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA TRACHOMATIS GENITAL INFECTION AND GONORRHEA, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HEPATITIS, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL-ACQUIRED INFECTIONS, BY STATE, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HUMAN IMMUNODEFICIENCY VIRUS, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HUMAN PAPILLOMAVIRUS, BY STATE, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INFLUENZA, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS, BY STATE, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ACADEMIC/RESEARCH INSTITUTES, BY STATE, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL/CLINICAL LABORATORIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PHYSICIAN OFFICES, BY STATE, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REFERENCE LABORATORIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 20. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET: SCORES
TABLE 21. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET: BUSINESS STRATEGY
TABLE 22. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET: PRODUCT SATISFACTION
TABLE 23. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET: RANKING
TABLE 24. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 25. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET: MERGER & ACQUISITION
TABLE 26. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 27. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 28. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET: INVESTMENT & FUNDING
TABLE 29. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 30. UNITED STATES HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS MARKET: LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Biomérieux SA
Co-Diagnostics Inc.
Danaher Corporation
DiaSorin S.p.A.
DNAe Group Holdings Ltd
GNA Biosolutions GmbH
Luminex Corporation
Meridian Bioscience Inc.
Quidel Corporation
Roche Holding AG
Siemens Healthineers AG
Thermo Fisher Scientific Inc.